Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Clinical Perspectives on Motivational Interviewing in Diabetes Care

  1. Marc Steinberg, MD, FAAP
Diabetes Spectrum 2011 Aug; 24(3): 179-181. https://doi.org/10.2337/diaspect.24.3.179
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

During the past two decades, prolific development has occurred in the areas of medication and self-management technology options for people with diabetes. No other time period since the introduction of insulin therapy in the 1920s has seen such significant improvements in diabetes care. However, despite these improvements, there are still sizable gaps in quality outcomes for people with diabetes. These gaps in care are manifested in research reflecting that overwhelming numbers of people with diabetes do not meet guidelines for glycemic control, blood pressure, and lipid levels.1,2 These care gaps are also accompanied by challenges clinicians experience in facilitating behavior change across the entire spectrum of diabetes care: physical activity, diet, weight loss, regular use of medications, and the use of well-established algorithms linking self-monitoring of blood glucose to medication and lifestyle self-management.

We, as clinicians, experience pain and frustration when our patients with diabetes develop complications that could have been delayed or prevented by enhanced self-management. But few of us received training to prepare us for the seemingly daunting tasks of working with the ambivalence, resistance, depression, and burnout that many experience living with diabetes. Few illnesses affect as many aspects of life as diabetes.3

For decades, I practiced in primary care with a special interest in diabetes. After pursuing additional training, I transitioned my practice several years ago to working exclusively in diabetes care with a special interest in the behavioral aspects of self-management. My practice now is populated by referrals from other clinicians to see people who are struggling with or completely neglecting their diabetes self-management. In this article and a second one that will be published in the next issue of Diabetes Spectrum, I will share perspectives on motivational interviewing (MI). This collaborative approach to diabetes care offers clinicians who are willing to consider changes in the way they practice the opportunity to more enjoyably and effectively address the most challenging area of diabetes care: facilitating people's efforts to improve their diabetes self-management.

In reviewing the development of MI, Miller and Rose4 describe Miller's early work in the 1980s using MI as a successful empathic counseling treatment for alcoholism. In 1989, Miller met Stephen Rollnick, and in 1991, they wrote the first textbook describing this successful approach for improving outcomes in the treatment of addictive disorders.5 Since then, the use of MI has expanded as a strategic approach to helping people with mental health disorders and chronic medical illnesses. It has been used for high-risk behavior prevention and by corrections officials in many different countries working with people who are incarcerated, paroled, or on probation. MI involves creating a safe setting for people to consider change. It also involves specific skills for guiding people toward the achievement of their goals.

Some of the research evidence for MI effectiveness in diabetes care has been equivocal, but this does not eliminate the usefulness of MI as an approach. Research on behavioral interventions is challenging. Such interventions cannot be applied in double-blinded crossover studies, a model often used in pharmaceutical research. Participants in clinical research studies easily recognize changes in verbal and empathic approaches to care, which compromises the use of blinded studies in behavioral research. And research clinicians may have varied skills in applying the experimental interventions. The research presented here supports this strongly patient-centered process of working with people to facilitate behavior change.

Describing to people the potential complications of their conditions rarely results in behavior change.6 People infrequently initiate change based on fear tactics emphasizing future suffering when they are already burdened by pain and challenges with their diabetes and with other important areas of their lives. Also, people often disengage from changes when they are subjected to clinician lectures on statistics or facts.

Clinicians using the spirit of MI seek to foster a compassionate environment in which to engage people in discussions that guide toward eliciting their reasons and plans for the changes they wish to make. This process of evoking “change talk” results in patient language relating their desires for improvements beyond the status quo. This trajectory toward changes in behavior can involve broader lifestyle changes, including perspectives on a topic, changes in self-perception, and even basic values.7 As people increase change talk, the likelihood of change occurring also increases.8

MI respects individuals' autonomy. Evoking change talk guides people in their choices about initiating change, in contrast to directing them to what we think they should do. After all, what occurs after a clinic visit is entirely dependent on decisions people make on their own. The unique interactions facilitated by MI supports people in “writing their own prescriptions” from the manifold options available to them.

Engaging patients in the clinical relationship is an essential element of MI. Without engagement, it is not possible to use MI. Exploring disengagement with people and observing how we behave during our interviews in the context of the spirit of MI facilitates engagement.

The Transtheoretical Model (TTM) of behavior change combines numerous psychological theories of behavior change.9 Miller and Rollnick pointed out in 2009 that MI is not based on TTM.10 TTM simply facilitates an understanding of the hard work and time people need to undertake change. Also, awareness of the stages of change—Precontemplation, Contemplation, Preparation, Action, and Maintenance—can help to guide engagement strategies with patients.

Many of the patients we see do not come to discuss change. Research on TTM has revealed that 92–96% of health plan enrollees are in the Precontemplation or Contemplation stages of change concerning smoking cessation, healthier eating, and increased physical activity.11 People in Precontemplation are not considering any behavior changes. Those in Contemplation may consider change for months as they weigh the pros and cons of choices with ambivalence. Engagement involves working with people using approaches tailored for where they are on the continuum of considering change.

In Precontemplation, patients prefer the status quo and use what MI views as “sustain language.” People speaking like this are very likely to resist or ignore clinicians' insistences to change. To facilitate engagement, asking an open-ended question about patients' previous experiences initiating beneficial changes in other life areas can be used to affirm their expertise in the challenging work of making changes. Exploring the future aspirations for their life is another opportunity to ask speculative questions. “How does your diabetes fit into this plan?” “Are there any diabetes issues that could have an influence on the desires you have for the future?” “I know you are not interested in physical activity, and I am not trying to force it on you, but can you think of any benefits for you by being more active?”

Change is a process, and it does not occur immediately. It may take months or years. So the most important clinical issue in Precontemplation is patients' willingness to return. Embracing a collaborative spirit, honoring self-efficacy, and avoiding arguments for change can strengthen people's desire for a return appointment. “Rolling with resistance” is an integral part of MI. Arguing with people for change encourages them to defend behaviors that do not enhance self-management, making the process of change more unlikely.

Ambivalence is the hallmark of the Contemplation stage. The challenges of making a decision in the midst of pros and cons can immobilize change. Although value exists in understanding people's barriers (cons) for change, guiding in Contemplation involves eliciting change talk to increase the likelihood of change. As in other stages of change, using MI in conversation consists of rolling with any resistance, offering empathy, and embracing collaborative guiding.

Ironically, our desire to help people can interfere with them initiating healthy changes. In our desire to help, we may resort to trying persuasively to “get them” to initiate a healthier lifestyle. Clinicians fall into this trap, called the “righting reflex,” because of their desire to help people. And many of us have seen the common outcome of this approach; people entrenched in ambivalence or the status quo rarely respond to persuasion or the “good reasons” we give them for change. Awareness of our own behaviors in interviews can free us from the righting reflex.

Some people come to appointments ready to make changes. “I am having problems with hypoglycemia around 3:00 or 4:00 a.m. It bothers me and my husband a lot.” This patient is troubled by a problem and has been unable to find a solution for it. It should be addressed directly.

People in this Preparation stage are exploring how to change. Having a realistic, achievable plan is essential for success. But MI can be used here, too. Rather than immediately providing solutions, we have an opportunity to confirm engagement and approach this with a truly patient-centered perspective. She knows what would likely work best for her. Ask her permission (“Would it be helpful to review some options for dealing with the lows that concern you?”). She can then confirm her engagement with, “Yes,” and open the door to collaboration. When she makes a choice among options, she gains ownership of the decision. This honors both self-efficacy and autonomy. She becomes the expert in choosing new work she will do for her diabetes.

Commitment language is the focus with people speaking about change. In contrast to the desire expressed in change talk, commitment language expresses a person's willingness to begin the difficult work of making a specific change. There are important features of both change and commitment language that can help clinicians judge a patient's strength of desire or commitment to change.

Compare the strength of desire for physical activity expressed in the following statements. “I might be able to fit in 15 to 20 minutes of walking by not driving to work.” “I am going to walk to work in the future.” “I really need the physical activity of walking to work. I would feel better.” Commitment language reveals the similar range of feelings about adopting a change. “I think I can do more pre-meal blood glucose testing so I can adjust my insulin properly.” “I will try to do more premeal blood glucose testing, so I can avoid highs and lows after eating.” “I bought a new meter to keep at work, so my plan for testing will work better.” These examples emphasize the importance of careful listening so we can work with people more effectively in the guiding process. In the first two statements in each set of examples, more collaboration needs to occur before changes will succeed. Research confirms that the stronger the commitment language is, the higher the success rate in initiating behavior change will be.12

Miller has said, “MI is basically simple, but learning it is not easy” (Miller WR,uUnpublished observations, 27 October 2010). These perspectives on MI offer an opportunity to better understand how this approach to care can work in daily clinical practice. In the next issue of Diabetes Spectrum, we will look more closely at some of the skills used in MI, describe some strategies for dealing with resistance, and discuss ways that interested clinicians can gain competency for using MI in their practices.

Acknowledgments

The author wishes to thank Michael Fulop, PsyD, for reviewing and assisting in the editing of this article.

Footnotes

  • Marc Steinberg, MD, FAAP, is director of TheGroup4QualityCare and a diabetes physician at Western Montana Clinic in Missoula, Mont.

  • Editor's note: Motivational interviewing (MI) is a collaborative counseling strategy that engages people in conversations that guide them toward strengthening their motivation to change behaviors. This article and a subsequent one that will appear in the next issue of Diabetes Spectrum explore clinical aspects of using MI in diabetes practice.

  • American Diabetes Association(R) Inc., 2011

References

  1. ↵
    1. Sayadah SH,
    2. Franklin J,
    3. Cowie CC
    : Poor control of vascular risk factors among adults with previously diagnosed diabetes. JAMA 291:336–342, 2004
    OpenUrl
  2. ↵
    1. McGlynn EA,
    2. Asch SM,
    3. Adams J,
    4. Keesey J,
    5. Hicks J,
    6. DeCristofaro A,
    7. Kerr EA
    : The quality of health care delivered to adults in the United States. N Engl J Med 348:2635–2645, 2003
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Rubin RR
    : Facilitating self-care in people with diabetes. Diabetes Spectrum 14:55–57, 2001
    OpenUrlFREE Full Text
  4. ↵
    1. Miller WR,
    2. Rose GS
    : Toward a theory of motivational interviewing. Amer Psychol 64:527–537, 2009
    OpenUrl
  5. ↵
    1. Miller WR,
    2. Rollnick S
    : Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, Guilford Press, 1991
  6. ↵
    1. Marteau TM,
    2. French DP,
    3. Griffin SJ,
    4. Prevost AT,
    5. Sutton S,
    6. Watkinson C,
    7. Attwood S,
    8. Hollands GJ
    : Effects of communicating DNA-based disease risk estimates on risk-reducing behaviors. Cochrane Database Sys Rev CD007275, 2010
  7. ↵
    1. Wagner CC,
    2. Ingersoll KS
    : Beyond behavior: eliciting broader change with motivational interviewing. J Clin Psychol 65:1180–1194, 2009
    OpenUrlPubMed
  8. ↵
    1. Magill M,
    2. Apodaca TR,
    3. Barnett NP,
    4. Monti PM
    : The route to change: within-session predictors of change plan completion in a motivational interview. J Subst Abuse Treat 38:299–305, 2010
    OpenUrlPubMed
  9. ↵
    1. Prochaska JO,
    2. Velicer WF
    : The Transtheoretical Model of health behavior change. Am J Health Promot 12:38–48, 1997
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Miller WR,
    2. Rollnick S
    : Ten things that motivational interviewing is not. Behav Cogn Psychother 37:129–140, 2009
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. O'Connor PJ,
    2. Rush WA,
    3. Prochaska JO,
    4. Pronk NP,
    5. Boyle RG
    : Professional advice and readiness to change behavioral risk factors among members of a managed care organization. Am J Manag Care 7:125–130, 2001
    OpenUrlPubMedWeb of Science
  12. ↵
    1. Amrhein PC,
    2. Miller WR,
    3. Yahne CE,
    4. Palmer M,
    5. Fulcher L
    : Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol 71:862–878, 2003
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Spectrum: 24 (3)

In this Issue

August 2011, 24(3)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Perspectives on Motivational Interviewing in Diabetes Care
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clinical Perspectives on Motivational Interviewing in Diabetes Care
Marc Steinberg
Diabetes Spectrum Aug 2011, 24 (3) 179-181; DOI: 10.2337/diaspect.24.3.179

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Clinical Perspectives on Motivational Interviewing in Diabetes Care
Marc Steinberg
Diabetes Spectrum Aug 2011, 24 (3) 179-181; DOI: 10.2337/diaspect.24.3.179
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Mental Health and Behavioral Screening in Pediatric Type 1 Diabetes
Show more Departments

Lifestyle and Behavior

  • Perceptions of Diabetes Self-Efficacy and Glycemic Control in Youth With Type 1 Diabetes
  • Global Well-Being Is Associated With A1C and Frequency of Self-Monitoring of Blood Glucose in Predominately Latinx Youth and Young Adults With Type 1 Diabetes
  • Driving Safety in Adolescents and Young Adults With Type 1 Diabetes
Show more Lifestyle and Behavior

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.